Trials / Conditions / Imatinib
Imatinib
4 registered clinical trials studyying Imatinib.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure NCT04677439 | Shenzhen Second People's Hospital | Phase 4 |
| Completed | An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints NCT01216085 | Novartis Pharmaceuticals | Phase 2 |
| Unknown | Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib NCT01564836 | Seoul St. Mary's Hospital | N/A |
| Completed | Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy NCT01316458 | Novartis Pharmaceuticals | Phase 2 |